Medical network - on February 23, skin disease has the characteristics of difficult to cure, easy to relapse after cure. Affected by the quickening pace of life and environmental degradation, skin disease incidence is rising year by year. According to different causes, the general will be divided into skin disease medication, eczema, fungal infections, bacterial infections, acne, psoriasis, etc., the higher the incidence of fungal infection. In skin disease medication, antifungal drugs are the main drugs.
Kang, according to data from the CMH 2015 skin antifungal drug sales of 5.36 billion yuan, up 9.5% from a year earlier, accounting for 26.2% of the overall skin disease drug market. Such large consumption and rising market demand, make the skin antifungal drugs become each big pharmaceutical manufacturers to market competition in the market.
Skin antifungal drugs in 2013-2015 market size and growth
From kang CHM data as you can see, in the top 10 enterprises in 2015, xi 'an yeung sum pharmaceutical status strength, market share of over 20.0% in 2015, yunnan hong pharmaceutical well, share close to 20.0%, other manufacturers share of less than 10.0%. Top 10 manufacturers combined share of 70.7% in 2015, 2014 fell 0.2% year-on-year. In the top 10, top two yeung sum of xi 'an pharmaceutical and dian hong pharmaceutical are foreign companies, the other eight are all domestic enterprises.
Skin antifungal medicine 2015 top 10 manufacturers
To count the skin under the antifungal medicine need manufacturer performance:
NO. 1 xi 'an yeung sum pharmaceutical
Kang, according to data from the CMH 2015 xi 'an yeung sum pharmaceutical antifungal drug sales of 1.49 billion yuan, up 9.7% from a year earlier, accounting for 28.3% of the total skin antifungal market, ranking first. Continuous advertising makes its product sales across the yoy growth, multi-brand strategy to stabilize the market position of xi 'an yeung sum, its gold daktarin, daktarin, perry pine brands are referred to as the domestic well-known brand antifungal drug.
Gold daktarin (ketone health zun cream) is the knock-out product of xi 'an yeung sum pharmaceutical, in 2015 the product accounted for 77.6% of the whole ketone health zun market, is outshine others. Daktarin (miconazole nitrate cream) introduced by xi 'an yeung sum of the Chinese market in 1989, with 72.9% market share for the products lead the whole miconazole markets; Perry pine (triamcinolone acetonide econazole cream) another blockbuster xian yeung sum pharmaceutical products, accounting for the entire triamcinolone acetonide econazole, 43.9% of the market is also difficult to encounter rivals in the market.
NO. 2 dian hong pharmaceutical industry
2015 yunnan rainbow pharmaceutical industry with sales of 1 billion yuan, ranking the second account for 19.2% of the total skin antifungal market. Rainbow pharmaceutical industry, the main products for the extract epurated from yunnan (compound ketone health zun with lotion), extract epurated from 2015 sales account for 13.8% of the whole skin antifungal market, is the skin antifungal market's best-selling products, at the same time, the product 85.5% of compound ketone health zun market, overwhelmingly graced the compound ketone health zun market.
In addition, yunnan rainbow pharmaceutical industry also has compound ketone health zun cream, compound ketone health zun ointment and hydrochloric acid than naphthalene cream three products, in 2015 the three product's market share is less than 3%.
NO. 3 correction pharmaceutical co.
2015 revised pharmaceutical sales ranked third, with 360 million yuan accounted for 6.8% of overall skin antifungal market. Wei da ning (econazole nitrate spray) as the correction pharmaceutical fist products, in 2015, wei da ning (econazole nitrate spray) sales of 350 million yuan, accounting for 98.0% of the correction pharmaceutical.
NO. 4 in chengdu nine cheese international pharmaceutical industry
Chengdu in 2015 # 9 cheese international pharmaceutical sales of 170 million yuan, accounting for 3.2% of the total skin antifungal market. Chengdu nine zhi hall all international pharmaceutical sales are complex sophora salicylic acid powder (sichuan # 9 cheese kingdom) contributions.
NO. 5 of qilu pharmaceutical
Qilu pharmaceutical sales of 140 million yuan in 2015, accounting for 2.7% of the total skin antifungal market. Qilu pharmaceutical, dink (hydrochloric acid than naphthalene Finn cream) mainly play products, accounting for 72.7% share of qilu pharmaceutical, dink (hydrochloric acid than naphthalene fragrance spray) sales slightly.
NO. 6 in fujian Pacific pharmaceutical
Fujian Pacific pharmaceutical sales of 140 million yuan in 2015, accounting for 2.7% of the total skin antifungal market. Fujian Pacific pharmaceutical sales mainly by triamcinolone acetonide econazole cream Pacific (fujian), and the rest of the miconazole nitrate cream (fujian Pacific), ketone health zun cream (fujian Pacific), biphenyl benzyl cream (fujian) Pacific, miconazole clobetasol cream (fujian) Pacific four products total contribution rate of less than 15.0%.
NO. 7 medicine pharmacy
General medicine pharmaceutical sales of 140 million yuan in 2015, accounting for 2.3% of the total skin antifungal market. Decongestants pharmaceutical sales mainly from econazole nitrate spray (decongestants pharmaceutical group), and the rest of the hydrochloric acid, naphthalene Finn cream (decongestants pharmaceutical group) and econazole nitrate cream (decongestants pharmaceutical group), hydrochloric acid, than naphthalene fragrance gel (decongestants pharmaceutical group) three products total contribution rate of less than 15.0%.
NO. 8 chongqing winbond pharmaceutical
In 2015, chongqing winbond pharmaceutical sales of 140 million yuan, accounting for 2.0% of the total skin antifungal market. Chongqing winbond pharmaceutical, there are three products, respectively, will be bright for Finn ketone health zun cream (naphthalene), v (biphenyl benzyl azole gel) triamcinolone acetonide and econazole cream winbond pharmaceutical (chongqing), the contribution rate of 75.4%, 18.4% and 6.1%, respectively.
NO. 9 CRC san-jiu medicine
In 2015 China resources san-jiu pharmaceutical sales of 140 million yuan, accounting for 1.8% of the total skin antifungal market. More products of huarun san-jiu pharmaceutical group, main for triamcinolone acetonide econazole cream (CRC) lump-sum, contributed 60.7% of sales, the rest of the contribution rate of each product.
NO. 10 Yellowstone health pharmaceutical materials
Yellowstone in 2015 health materials pharmaceutical sales of 140 million yuan, accounting for 1.8% of the total skin antifungal market. Yellowstone health materials pharmaceutical industry's only a product, for salicylic acid phenol adminstration (Yellowstone health materials). |
